{"entity":{"type":"insider","cik":"0001890152","url":"/insider/0001890152","json_url":"/insider/0001890152.json","name":"C2 Life Sciences LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2021-11-03","last":"2022-08-22","span_basis":"filed_date"},"name_variants":[{"name":"C2 Life Sciences LLC","source":"filing","n_filings":5,"first_seen":"2021-11-03","last_seen":"2022-08-22"}],"transactions":[{"id":6170178,"accession":"0001062993-22-018544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-018544","line_url":"/filing/0001062993-22-018544#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings, LP; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":998240.0,"shares_display":"998,240","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":2395776.0,"total_display":"2,395,776.00","shares_owned_after":3728491.0,"shares_owned_after_display":"3,728,491","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-22","scope":"insider"},{"id":6695504,"accession":"0001062993-22-013616","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-013616","line_url":"/filing/0001062993-22-013616#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings, LP; C2 Life Sciences LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; LEV LB Holdings GP, LLC; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69000.0,"shares_display":"69,000","price_per_share":3.13,"price_display":"3.13","price_state":"stated","total_value":215970.0,"total_display":"215,970.00","shares_owned_after":2730251.0,"shares_owned_after_display":"2,730,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-27","scope":"insider"},{"id":6717151,"accession":"0001062993-22-013535","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-013535","line_url":"/filing/0001062993-22-013535#line-3","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; EDELMAN JOSEPH; LEV LB Holdings, LP; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120000.0,"shares_display":"120,000","price_per_share":2.63,"price_display":"2.63","price_state":"stated","total_value":315600.0,"total_display":"315,600.00","shares_owned_after":2661251.0,"shares_owned_after_display":"2,661,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-25","scope":"insider"},{"id":6717149,"accession":"0001062993-22-013535","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-013535","line_url":"/filing/0001062993-22-013535#line-2","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; EDELMAN JOSEPH; LEV LB Holdings, LP; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42551.0,"shares_display":"42,551","price_per_share":2.47,"price_display":"2.47","price_state":"stated","total_value":105100.97,"total_display":"105,100.97","shares_owned_after":2541251.0,"shares_owned_after_display":"2,541,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider"},{"id":6717145,"accession":"0001062993-22-013535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-013535","line_url":"/filing/0001062993-22-013535#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; EDELMAN JOSEPH; LEV LB Holdings, LP; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8700.0,"shares_display":"8,700","price_per_share":2.49,"price_display":"2.49","price_state":"stated","total_value":21663.0,"total_display":"21,663.00","shares_owned_after":2498700.0,"shares_owned_after_display":"2,498,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider"},{"id":4718855,"accession":"0001062993-21-010295","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-010295","line_url":"/filing/0001062993-21-010295#line-2","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings GP, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; LEV LB Holdings, LP; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; PERCEPTIVE ADVISORS LLC; C2 Life Sciences LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2250000.0,"shares_display":"2,250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":36000000.0,"total_display":"36,000,000.00","shares_owned_after":27838895.0,"shares_owned_after_display":"27,838,895","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-05","scope":"insider"},{"id":4718849,"accession":"0001062993-21-010295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-010295","line_url":"/filing/0001062993-21-010295#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings GP, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; LEV LB Holdings, LP; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; PERCEPTIVE ADVISORS LLC; C2 Life Sciences LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":13.51,"price_display":"13.51","price_state":"stated","total_value":270200.0,"total_display":"270,200.00","shares_owned_after":27858895.0,"shares_owned_after_display":"27,858,895","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-05","scope":"insider"},{"id":4163906,"accession":"0000899243-21-042807","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-042807","line_url":"/filing/0000899243-21-042807#line-2","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings, LP; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":1350000.0,"total_display":"1,350,000.00","shares_owned_after":7253885.0,"shares_owned_after_display":"7,253,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":4163901,"accession":"0000899243-21-042807","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-042807","line_url":"/filing/0000899243-21-042807#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings, LP; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120000.0,"shares_display":"120,000","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":1860000.0,"total_display":"1,860,000.00","shares_owned_after":7153885.0,"shares_owned_after_display":"7,153,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831283","name":"LianBio","url":"/issuer/0001831283","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2021-11-03","last_seen":"2022-08-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001890152","retrieved_at":"2026-08-21T00:54:34+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}